| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.012 | 0.9 |